Trials / Completed
CompletedNCT01432379
BOTOX® Prophylaxis in Patients With Chronic Migraine
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,168 (actual)
- Sponsor
- Allergan · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a post authorization observational study to monitor the utilization practices and describe the safety profile of BOTOX® in clinical practice for the prophylactic treatment of headaches in adult patients with chronic migraine.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | botulinum toxin Type A | 155-195 U of botulinum toxin Type A administered intramuscularly in the face, head, and neck areas as directed by physician (approximately every 12 weeks) for 1 year. |
Timeline
- Start date
- 2011-09-09
- Primary completion
- 2015-05-12
- Completion
- 2015-05-12
- First posted
- 2011-09-13
- Last updated
- 2019-01-08
- Results posted
- 2016-12-12
Locations
4 sites across 4 countries: Germany, Spain, Sweden, United Kingdom
Source: ClinicalTrials.gov record NCT01432379. Inclusion in this directory is not an endorsement.